Difficulty: Medium
Average Score: 62%
Practice
A 25-year-old man with HIV disease presents to his primary care physician for management. His CD4 counts are dramatically lower than normal. He is being considered for therapy with protease inhibitors. Regarding the role of ritonavir in this patient, which of the following statements is true?
Correct answer
C
Rationale
In the context of HIV treatment, ritonavir plays a crucial role as a pharmacokinetic enhancer when used in combination with other protease inhibitors. The correct answer, option C, states that ritonavir can potentiate therapy when used with other protease inhibitors. Ritonavir inhibits CYP3A enzyme, which leads to increased plasma levels of other protease inhibitors when co-administered. This enhancement allows for lower doses of other protease inhibitors to be used, reducing side effects and improving efficacy.
Option A is incorrect because ritonavir predominantly inhibits CYP3A, not CYP4A. Option B is incorrect as ritonavir is not used as a single agent due to its primary role as a pharmacokinetic enhancer. Option D is incorrect as ritonavir actually helps to prevent the development of resistance when used in combination with other protease inhibitors by maintaining therapeutic drug levels.
In an educational context, understanding the role of ritonavir in HIV treatment is crucial for healthcare providers managing patients with HIV disease. This knowledge helps optimize therapy, improve patient outcomes, and prevent the development of drug resistance. Educating healthcare professionals about the mechanisms of action and interactions of antiretroviral drugs is essential in providing quality care to patients with HIV.
Option A is incorrect because ritonavir predominantly inhibits CYP3A, not CYP4A. Option B is incorrect as ritonavir is not used as a single agent due to its primary role as a pharmacokinetic enhancer. Option D is incorrect as ritonavir actually helps to prevent the development of resistance when used in combination with other protease inhibitors by maintaining therapeutic drug levels.
In an educational context, understanding the role of ritonavir in HIV treatment is crucial for healthcare providers managing patients with HIV disease. This knowledge helps optimize therapy, improve patient outcomes, and prevent the development of drug resistance. Educating healthcare professionals about the mechanisms of action and interactions of antiretroviral drugs is essential in providing quality care to patients with HIV.